Ablynx N.V.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule

Other Names/Subsidiaries

  • Ablynx NV
See more in Biomedtracker

Latest on Ablynx N.V.

Scrip

Global First Approval For Daiichi’s EZH1/2 Inhibitor Valemetostat In Japan

 
• By Lisa Takagi

Japan has given the first approval anywhere globally to Daiichi Sankyo Co., Ltd. ’s dual inhibitor of EZH1 (enhancer of zeste homolog 1) and EZH2 Ezharmia (valemetostat; DS-3201), for the treatment o

Scrip

What Sanofi Early Research Chief Scientist Frank Nestle Is Most Excited About

 
• By Jessica Merrill

Sanofi 's approach to drug discovery and early pipeline development has been changing over the last five years, and global head of research and chief scientific officer Frank Nestle said in an intervi

Scrip

Sanofi Continues Hunt For External Innovation With Skyhawk Deal

 
• By Alaric DeArment

Who: Sanofi and Skyhawk Therapeutics, Inc. What: The two companies have signed an exclusive worldwide partnership to discover and develop small molecule drugs in immunology and oncology using Skyha

In Vivo

What Sanofi Early Research Chief Scientist Frank Nestle Is Most Excited About

 
• By Jessica Merrill

Sanofi 's approach to drug discovery and early pipeline development has been changing over the last five years, and its global head of research and chief scientific officer Frank Nestle told In Vivo